Doctor of Nursing Practice Projects
A Policy Analysis of Spinraza: An Orphan Drug for Spinal Muscular Atrophy
Description
PURPOSE An examination and evaluation of current policies of private, state, and federal insurance payers regarding approval of Spinraza for use in individual children will lead to recommendations for changes in local payment protocols and organizational involvement related to need for federal policies/regulations/guidelines for Spinraza/UODs for 5q-SMA
This paper has been withdrawn.